Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — August 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • K Offline
    K Offline
    kkjoel
    wrote on sidst redigeret af
    #231

    @mollegade Og i artikelen ("Genmabtopchef: Darzalex' salg kan accelerere væsentligt") fra april i Børsen giver direktør Winkel en fin overflyning på Darzalex' markedsposition/hovedtriggere de kommende par år: http://borsen.dk/nyheder/virksomheder/artikel/1/361103/genmabtopchef_darzalex_salg_kan_accelerere_vaesentligt.html

    1 Reply Last reply
    0
    • K Offline
      K Offline
      kkjoel
      wrote on sidst redigeret af
      #232

      Og her en fin lille artikel om Darzalex' salgsdudvikling fra juli i Børsen efter 2Q salgstallene kom fra JNJ http://borsen.dk/nyheder/virksomheder/artikel/1/365823/salget_af_genmabs_guldaeg_overgaar_alle_forventninger.
      html

      1 Reply Last reply
      0
      • K Offline
        K Offline
        kkjoel
        wrote on sidst redigeret af
        #233

        Ups... http://borsen.dk/nyheder/virksomheder/artikel/1/365823/salget_af_genmabs_guldaeg_overgaar_alle_forventninger.html

        1 Reply Last reply
        0
        • D Offline
          D Offline
          dohk
          wrote on sidst redigeret af
          #234

          Morphosys kører videre med deres kinesiske partner I-mab: https://finance.yahoo.com/n
          ews/dgap-news-morphosys-mab-biopharma-011500009.html

          1 Reply Last reply
          0
          • D Offline
            D Offline
            dohk
            wrote on sidst redigeret af
            #235

            Link Preview Image
            DGAP-News: MorphoSys and I-Mab Biopharma Announce China IND Submission of TJ202/MOR202

            NASDAQ: MOR) and I-Mab Biopharma ("I-Mab"), a Shanghai-based biotech company focused on innovative biologics in oncology and autoimmune diseases, announced today that I-Mab has submitted an investigational new drug (IND) application to China National Drug Administration (CNDA) for TJ202/MOR202, a human monoclonal antibody directed against CD38 for the treatment of multiple myeloma. Multiple myeloma is the second most common blood cancer worldwide. The patient number has gradually increased in China in recent years due to an increasingly aging population.

            favicon

            Yahoo Finance (finance.yahoo.com)

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bibob
              wrote on sidst redigeret af
              #236

              Det kunne jo være at kineserne fik øjnene op for Dara , da det jo er succesfuldt mod cd38. Hvorfor så vente på noget ringere. 😉

              1 Reply Last reply
              0
              • T Offline
                T Offline
                Tandfeen-2
                wrote on sidst redigeret af
                #237

                Kan jeg stille spørgsmål til Q & A her: What is the status for the subcutan version of Darzalex? And what is the status for darzalex in rheumatological diseases?

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #238

                  Hvorfor ikke direkte i Q&A chatten lige nu?

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #239

                    Du melder dig til her. http://www.proinvestor.com/index.php?p=q-and-a&groupid=92

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #240

                      Derefter kan du stille spørgsmålet i Q&A chatten. Den finder du i drop down boxen.

                      1 Reply Last reply
                      0
                      • T Offline
                        T Offline
                        Tandfeen-2
                        wrote on sidst redigeret af
                        #241

                        Jeg prøver der

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #242

                          Tak Tandfe...Spørgsmålet er gået ind.

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #243

                            http://globenewswire.com/news-release/2018/08/08/1548832/0/en/Genmab-Announces-Submission-of-U-S-EU-Regulatory-Applications-Seeking-Approval-of-DARZALEX-Daratumumab-Split-Dosing-Regimen.html

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #244

                              Genmab Announces Submission of U.S. & EU Regulatory Applications Seeking Approval of DARZALEX® (Daratumumab) Split Dosing Regimen

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #245

                                nice timing

                                1 Reply Last reply
                                0
                                • T Offline
                                  T Offline
                                  Tandfeen-2
                                  wrote on sidst redigeret af
                                  #246

                                  Får det nogen betydning?

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Peter_Panik
                                    wrote on sidst redigeret af
                                    #247

                                    Nordea atter største nettosælger

                                    1 Reply Last reply
                                    0
                                    • K Offline
                                      K Offline
                                      kkjoel
                                      wrote on sidst redigeret af
                                      #248

                                      Helge, fik du mit spørgsmål i Q&A chatten?

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        kkjoel
                                        wrote on sidst redigeret af
                                        #249

                                        Nordnets nyhedstelegram om split dosing https://www.nordnet.dk/mux/web/analys/nyheter/visaNyhet.html?itemid=490848013&sourcecode=ddk

                                        1 Reply Last reply
                                        0
                                        • H Offline
                                          H Offline
                                          henrik48
                                          wrote on sidst redigeret af
                                          #250

                                          Kursen lader til at forberede sig på et hop op ad efter regnskab 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger